Search Within

Philip Wayne Kantoff

Formats
  1. Journal Article (118)
  2. Meeting Abstract (71)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (198)
  2. Genitourinary Oncology Service (198)
  3. Solid Tumor Oncology Division (198)
  4. Sloan Kettering Institute Postdocs (71)
  5. GSK Faculty (26)
  6. Human Oncology and Pathogenesis Program (23)

More Groups

People
  1. Konrad Stopsack (44)
  2. Goutam Chakraborty (29)
  3. Ying Mazzu (29)
  4. Subhiksha Nandakumar (27)
  5. Michael Morris (26)
  6. Yuki Yoshikawa (23)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (19)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (17)
  3. Cancer Research (16)
  4. Cancer (9)
  5. Cancer Epidemiology Biomarkers and Prevention (8)
  6. European Urology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. American Association for Cancer Research (46)
  3. Nature Publishing Group (16)
  4. Oxford University Press (11)
  5. Wiley Blackwell (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inferences about drug safety in phase III trials in oncology: Examples from advanced prostate cancer
    Journal Article

    Drago, J. Z.; Gönen, M.; Thanarajasingam, G.; Sacks, C. A.; Morris, M. J.; Kantoff, P. W.; Stopsack, K. H.
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save
  • Abiraterone acetate induces CREB1 phosphorylation and enhances the function of the CBP-p300 complex, leading to resistance in prostate cancer cells
    Journal Article

    Pan, W.; Zhang, Z.; Kimball, H.; Qu, F.; Berlind, K.; Stopsack, K. H.; Lee, G. S. M.; Choueiri, T. K.; Kantoff, P. W.
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Tackling diversity in prostate cancer clinical trials: A report from the Diversity Working Group of the IRONMAN registry
    Journal Article

    McKay, R. R.; Gold, T.; Zarif, J. C.; Chowdhury-Paulino, I. M.; Friedant, A.; Gerke, T.; Grant, M.; Hawthorne, K.; Heath, E.; Huang, F. W.; more...
    JCO Global Oncology (2021)

    Fulltext@MSK | Save
  • Benchmarks for academic oncology faculty
    Editorial

    Anthony, L.; Atweh, G.; Bhatia, R.; Carey, L. A.; Chang, J. C.; Edelman, M. J.; Kantoff, P. W.; Markham, M. J.; Messersmith, W.; Nelson, E. L.; more...
    JCO Oncology Practice (2021)

    Fulltext@MSK | Save
  • Combined inhibition of androgen signaling and apoptosis pathways in hormone sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Jehane, L. E.; Mazzu, Y. Z.; Yoshikawa, Y.; Rajanala, S. H.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Multiplex immunofluorescence in formalin-fixed paraffin-embedded tumor tissue to identify single-cell-level PI3K pathway activation
    Journal Article

    Stopsack, K. H.; Huang, Y.; Tyekucheva, S.; Gerke, T. A.; Bango, C.; Elfandy, H.; Bowden, M.; Penney, K. L.; Roberts, T. M.; Parmigiani, G.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Dual blockade of c-MET and the androgen receptor in metastatic castration-resistant prostate cancer: A phase I study of concurrent enzalutamide and crizotinib
    Journal Article

    Tripathi, A.; Supko, J. G.; Gray, K. P.; Melnick, Z. J.; Regan, M. M.; Taplin, M. E.; Choudhury, A. D.; Pomerantz, M. M.; Bellmunt, J.; Yu, C.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save